Awareness of physicians and pharmacists of aldosterone antagonists in heart failure and myocardial infarction in Jordan

about

Awareness of physicians and pharmacists of aldosterone antagonists in heart failure and myocardial infarction in Jordan

Item

http://www.wikidata.org/entity/Q41702156

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Awareness of physicians and ph ...... yocardial infarction in Jordan

@en

type

Item

label

Awareness of physicians and ph ...... yocardial infarction in Jordan

@en

prefLabel

Awareness of physicians and ph ...... yocardial infarction in Jordan

@en

P1476

Awareness of physicians and ph ...... yocardial infarction in Jordan

@en

P2093

Fadia Mayyas

http://www.w3.org/2001/XMLSchema#string

Khalid Ibrahim

http://www.w3.org/2001/XMLSchema#string

P2860

Mineralocorticoid receptor antagonists in patients with heart failure: current experience and future perspectives

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Aldosterone receptor antagonists: effective but often forgotten.

Impact of aldosterone antagonists on the substrate for atrial fibrillation: aldosterone promotes oxidative stress and atrial structural/electrical remodeling

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribut

Temporal Trends and Hospital Variation in Mineralocorticoid Receptor Antagonist Use in Veterans Discharged With Heart Failure.

Use of aldosterone antagonists in heart failure.

Temporal trends and predictors in the use of aldosterone antagonists post-acute myocardial infarction.

P304

994

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18549/PHARMPRACT.2017.03.994

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Karem H. Alzoubi

Fadia Mayyas

Khalid Ibrahim

P577

2017-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28943982

http://www.w3.org/2001/XMLSchema#string

P932

5597810

http://www.w3.org/2001/XMLSchema#string